Type 1 diabetes

Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy

DiabetologiaPublished Open-label extension study

Authors' conclusion

Repeated, on-demand FMT is effective and safe for long-term treatment of individuals with type 1 diabetes and severe diabetic gastroenteropathy.

Study context

Population
Individuals with T1D and diabetic gastroenteropathy from a prior RCT; followed September 2021 to December 2024of original 20
Participants
17 individuals
Comparison
Repeated on-demand faecal microbiota transplantation (FMT), after vs before treatment
  • FMTn = 17
Outcome
GSRS-IBS score (symptom assessments by telephone every 2-3 months)
Methodological detailsrepeated on-demand FMT, Median follow-up 33.2 months (range 14.7-39.1 months)
  • Repeated on-demand FMT
  • Median follow-up 33.2 months (range 14.7-39.1 months)

Main finding

As reported in the abstract

GSRS-IBS score · last FMT treatment vs baseline

Mean Gastrointestinal Symptom Rating Scale for Irritable Bowel Syndrome (GSRS-IBS) score at baseline

60

95% CI 54, 66

Mean GSRS-IBS score at last FMT treatment

35

95% CI 29, 40

Mean difference

−25

95% CI −18, −33

Further findings

Frequent bowel movements (> 7 per day) · 2 weeks after treatment

Before treatment
19% (95% CI 10%, 28%)
After treatment
3% (95% CI 0%, 7%)

Normal stool types (Bristol Stool Scale score 3-5)

Before treatment
28% (95% CI 18%, 39%)
After treatment
76% (95% CI 66%, 86%)

Participant satisfaction

Considerable benefits (Likert scores 5-7)
86%

Treatment exposure

Total FMT treatments
95
Median FMT treatments per participant
5
Median interval between treatments
5.3 months

Safety

Adverse events

Serious adverse events (AEs)
15
Serious AEs possibly related to FMT
1
Generally well tolerated; most AEs mild and self-limiting

Original publication

Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy. Diabetologia. Published 18 September 2025. doi:10.1007/s00125-025-06544-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.